(Update) Acalabrutinib in CLL and MCL
Acalabrutinib
Obinutuzumab
Update Venetoclax in CLL
NCCN Guidelines for Patients
NCCN COVID-19 Resources Page
Cancer.gov
ASH: COVID-19 Resources for Managing Blood Cancers